Join
Live feed
·
INSIDERFilingvia Quantisnow
Immunome Inc. logo

Director Bienaime Jean Jacques bought $46,900 worth of shares (5,000 units at $9.38), increasing direct ownership by 16% to 36,415 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
IMNM· Immunome Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMNM (Immunome Inc.) and more on Quantisnow.